145 related articles for article (PubMed ID: 23959264)
1. Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F
Strahlenther Onkol; 2013 Oct; 189(10):849-55. PubMed ID: 23959264
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Gebhard MP; Noack F; Bruchhage KL; Schild SE
Strahlenther Onkol; 2014 Jan; 190(1):68-74. PubMed ID: 23861152
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.
Seibold ND; Schild SE; Gebhard MP; Noack F; Schröder U; Rades D
Strahlenther Onkol; 2013 Jul; 189(7):559-65. PubMed ID: 23700207
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Rades D; Seibold ND; Gebhard MP; Noack F; Schild SE; Thorns C
Strahlenther Onkol; 2011 Oct; 187(10):626-32. PubMed ID: 21932027
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Rades D; Huttenlocher S; Seibold ND; Gebhard MP; Thorns C; Hasselbacher K; Wollenberg B; Schild SE
BMC Cancer; 2015 Mar; 15():102. PubMed ID: 25868613
[TBL] [Abstract][Full Text] [Related]
8. Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Hoffmann A; Gebhard MP; Noack F; Thorns C; Schild SE
Strahlenther Onkol; 2013 Oct; 189(10):856-60. PubMed ID: 23868550
[TBL] [Abstract][Full Text] [Related]
9. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
[TBL] [Abstract][Full Text] [Related]
10. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.
Rades D; Meyners T; Kazic N; Bajrovic A; Rudat V; Schild SE
Strahlenther Onkol; 2011 Sep; 187(9):541-7. PubMed ID: 21858415
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
[TBL] [Abstract][Full Text] [Related]
12. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).
Rades D; Setter C; Dunst J; Dahl O; Schild SE; Noack F
Strahlenther Onkol; 2010 Jun; 186(6):307-14. PubMed ID: 20437013
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.
Seidl D; Janssen S; Strojan P; Bajrovic A; Schild SE; Rades D
Anticancer Res; 2016 May; 36(5):2523-6. PubMed ID: 27127167
[TBL] [Abstract][Full Text] [Related]
15. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
18. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
19. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity.
Rades D; Ulbricht T; Hakim SG; Schild SE
Strahlenther Onkol; 2012 Jan; 188(1):42-8. PubMed ID: 22194029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]